Leukemia, Myelodysplasia, Transplantation

News

Transfusions, readmissions higher for patients with CLL after cardiac surgery

Author:

Mark S. Lesney, PhD

Publish date: September 20, 2021

Most other outcomes were similar for patients with and without CLL, including mortality and infection.

• Read More

Latest News

One in three cancer articles on social media has wrong info

Author:

Nick Mulcahy

Publish date: August 4, 2021

Physician says misleading information online may be harmful to patients.

• Read More

Conference Coverage

Ponatinib/blinatumomab start strong against Ph+ALL

Author:

Neil Osterweil

Publish date: June 25, 2021

The combined agents were associated with high complete response and molecular remission rates as frontline...

• Read More

Conference Coverage

Reduced-intensity transplant benefits older patients with AML

Author:

Nancy A. Melville

Publish date: June 22, 2021

This improvement in survival is seen regardless of key factors such as genotype and the status of minimal...

• Read More

Article

The power and promise of social media in oncology

Author:

Alan P. Lyss, MD

Publish date: May 3, 2021

Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.

• Read More

Clinical Topics & News

Atrial Fibrillation and Bleeding in Patients With Chronic Lymphocytic Leukemia Treated with Ibrutinib in the Veterans Health Administration

Author:

Kelli M. Rasmussen, MS

Vikas Patil, MS

Zachary Burningham, PhD

Christina Yong, MA

Brian C. Sauer, PhD

Ahmad S. Halwani, MD

Although ibrutinib is associated with increased bleeding-related adverse events, the risk for patients with chronic lymphocytic leukemia is...

• Read More

News

Predicting outcomes in therapy-related AML

Author:

Mark S. Lesney, PhD

Publish date: April 22, 2021

Among t-AML patients who underwent HSCT, a significant decrease in survival was associated with an increasing...

• Read More

News

GENUINE improvements: Ublituximab plus ibrutinib for CLL

Author:

Kate O’Rourke

Publish date: April 21, 2021

Ublituximab plus ibrutinib was superior to ibrutinib alone for patients with relapsed or refractory high-risk...

• Read More

News

Low-calorie diet linked to improved chemo response in leukemia

Author:

Nancy A. Melville

Publish date: April 14, 2021

The diet and exercise regimen is a departure from current recommendations for patients with leukemia.

• Read More

Article

Cancer screening stopped by pandemic: Repercussions to come?

Author:

Helen Leask

Publish date: April 8, 2021

Most health care systems stopped screening when the global pandemic hit. Will this lead to more advanced cancers...

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• last »